Phibro Animal Health Corp (PAHC) stock
PAHCNasdaqPharmaceutical PreparationsFiscal year ends June 30
Financials through Q4 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 22/3046% below fair value
$35.57+0.65 (+1.86%)
Close on Nov 18, 2026Market cap $1.44BP/E 14.6Yield 1.35%
Phibro Animal Health operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Phibro Animal Health's operating cash flow for the twelve months ending Jun 30, 2026 was $68.95M, down 13.9% year over year. For fiscal 2026 it was $68.95M, down 13.9% from the year before. Over ten years it grew 6.4% a year on average. The highest annual figure on record is $98.39M in fiscal 2017.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Jun 30, 2026 | $68.95M | -13.9% |
| FY2025 | Jun 30, 2025 | $80.12M | -8.5% |
| FY2024 | Jun 30, 2024 | $87.59M | +558.1% |
| FY2023 | Jun 30, 2023 | $13.31M | -57.9% |
| FY2022 | Jun 30, 2022 | $31.65M | -34.5% |
| FY2021 | Jun 30, 2021 | $48.31M | -18.6% |
| FY2020 | Jun 30, 2020 | $59.35M | +25.8% |
| FY2019 | Jun 30, 2019 | $47.17M | -32.6% |
| FY2018 | Jun 30, 2018 | $70.01M | -28.8% |
| FY2017 | Jun 30, 2017 | $98.39M | +164.3% |
| FY2016 | Jun 30, 2016 | $37.22M | -45.8% |
| FY2015 | Jun 30, 2015 | $68.70M | – |
| FY2014 | Jun 30, 2014 | -$712.00K | -149.5% |
| FY2013 | Jun 30, 2013 | $1.44M | -95.5% |
| FY2012 | Jun 30, 2012 | $31.99M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2026CQ2 2026 | Jun 30, 2026 | $24.09M | +13.3% |
| Q3 FY2026CQ1 2026 | Mar 31, 2026 | $16.21M | -62.4% |
| Q2 FY2026CQ4 2025 | Dec 31, 2025 | $19.35M | +529.1% |
| Q1 FY2026CQ3 2025 | Sep 30, 2025 | $9.30M | -26.3% |
| Q4 FY2025CQ2 2025 | Jun 30, 2025 | $21.27M | -25.2% |
| Q3 FY2025CQ1 2025 | Mar 31, 2025 | $43.15M | +278.3% |
| Q2 FY2025CQ4 2024 | Dec 31, 2024 | $3.08M | -90.3% |
| Q1 FY2025CQ3 2024 | Sep 30, 2024 | $12.62M | -22.1% |
| Q4 FY2024CQ2 2024 | Jun 30, 2024 | $28.43M | +40.5% |
| Q3 FY2024CQ1 2024 | Mar 31, 2024 | $11.41M | +82.3% |
| Q2 FY2024CQ4 2023 | Dec 31, 2023 | $31.56M | – |
| Q1 FY2024CQ3 2023 | Sep 30, 2023 | $16.20M | – |
| Q4 FY2023CQ2 2023 | Jun 30, 2023 | $20.24M | +1185.8% |
| Q3 FY2023CQ1 2023 | Mar 31, 2023 | $6.26M | +2.1% |
| Q2 FY2023CQ4 2022 | Dec 31, 2022 | -$2.49M | -112.4% |
| Q1 FY2023CQ3 2022 | Sep 30, 2022 | -$10.70M | -380.0% |
| Q4 FY2022CQ2 2022 | Jun 30, 2022 | $1.57M | -48.7% |
| Q3 FY2022CQ1 2022 | Mar 31, 2022 | $6.13M | -63.1% |
| Q2 FY2022CQ4 2021 | Dec 31, 2021 | $20.12M | -25.2% |
| Q1 FY2022CQ3 2021 | Sep 30, 2021 | $3.82M | +125.0% |
| Q4 FY2021CQ2 2021 | Jun 30, 2021 | $3.07M | -20.8% |
| Q3 FY2021CQ1 2021 | Mar 31, 2021 | $16.63M | -38.3% |
| Q2 FY2021CQ4 2020 | Dec 31, 2020 | $26.91M | -16.1% |
| Q1 FY2021CQ3 2020 | Sep 30, 2020 | $1.70M | – |
| Q4 FY2020CQ2 2020 | Jun 30, 2020 | $3.88M | -73.9% |
| Q3 FY2020CQ1 2020 | Mar 31, 2020 | $26.95M | +72.2% |
| Q2 FY2020CQ4 2019 | Dec 31, 2019 | $32.09M | +109.0% |
| Q1 FY2020CQ3 2019 | Sep 30, 2019 | -$3.57M | -378.9% |
| Q4 FY2019CQ2 2019 | Jun 30, 2019 | $14.88M | +47.2% |
| Q3 FY2019CQ1 2019 | Mar 31, 2019 | $15.65M | -31.4% |
| Q2 FY2019CQ4 2018 | Dec 31, 2018 | $15.36M | -52.4% |
| Q1 FY2019CQ3 2018 | Sep 30, 2018 | $1.28M | -73.3% |
| Q4 FY2018CQ2 2018 | Jun 30, 2018 | $10.11M | -25.5% |
| Q3 FY2018CQ1 2018 | Mar 31, 2018 | $22.81M | -38.5% |
| Q2 FY2018CQ4 2017 | Dec 31, 2017 | $32.29M | +22.9% |
| Q1 FY2018CQ3 2017 | Sep 30, 2017 | $4.80M | -77.6% |
| Q4 FY2017CQ2 2017 | Jun 30, 2017 | $13.58M | – |
| Q3 FY2017CQ1 2017 | Mar 31, 2017 | $37.08M | – |
| Q2 FY2017CQ4 2016 | Dec 31, 2016 | $26.28M | – |
| Q1 FY2017CQ3 2016 | Sep 30, 2016 | $21.46M | – |
See a number that looks wrong?